Shanghai Henlius Biotech, Inc. (2696.HK)

HKD 40.35

(3.59%)

Long Term Debt Summary of Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.'s latest annual long term debt in 2023 was 1.29 Billion CNY , up 11.93% from previous year.
Shanghai Henlius Biotech, Inc.'s latest quarterly long term debt in 2024 Q2 was 1.05 Billion CNY , down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported annual long term debt of 1.15 Billion CNY in 2022, up 9.76% from previous year.
Shanghai Henlius Biotech, Inc. reported annual long term debt of 1.05 Billion CNY in 2021, up 63.11% from previous year.
Shanghai Henlius Biotech, Inc. reported quarterly long term debt of 1.05 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported quarterly long term debt of 1.17 Billion CNY for 2023 Q1, up 2.04% from previous quarter.

Annual Long Term Debt Chart of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Historical Annual Long Term Debt of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Year	Long Term Debt	Long Term Debt Growth
2023	1.29 Billion CNY	11.93%
2022	1.15 Billion CNY	9.76%
2021	1.05 Billion CNY	63.11%
2020	645.13 Million CNY	94.82%
2019	331.14 Million CNY	-14.06%
2018	385.34 Million CNY	137.03%
2017	162.56 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	1.05 Billion CNY	-4.97%
2024 Q2	1.05 Billion CNY	0.0%
2023 Q1	1.17 Billion CNY	2.04%
2023 Q2	1.17 Billion CNY	0.0%
2023 Q4	1.29 Billion CNY	1.89%
2023 FY	1.29 Billion CNY	11.93%
2023 Q3	1.26 Billion CNY	7.65%
2022 Q2	1.1 Billion CNY	0.0%
2022 Q4	1.15 Billion CNY	18.42%
2022 Q3	975.29 Million CNY	-11.96%
2022 FY	1.15 Billion CNY	9.76%
2022 Q1	1.1 Billion CNY	5.27%
2021 Q1	977.27 Million CNY	51.49%
2021 FY	1.05 Billion CNY	63.11%
2021 Q4	1.05 Billion CNY	0.0%
2021 Q3	1.05 Billion CNY	7.67%
2021 Q2	977.27 Million CNY	0.0%
2020 Q2	267.08 Million CNY	0.0%
2020 FY	645.13 Million CNY	94.82%
2020 Q4	645.13 Million CNY	0.0%
2020 Q3	645.13 Million CNY	141.55%
2020 Q1	267.08 Million CNY	-19.35%
2019 FY	331.14 Million CNY	-14.06%
2019 Q1	522.61 Million CNY	35.62%
2019 Q4	331.14 Million CNY	0.0%
2019 Q3	331.14 Million CNY	-34.37%
2019 Q2	504.59 Million CNY	-3.45%
2018 Q3	385.34 Million CNY	0.0%
2018 FY	385.34 Million CNY	137.03%
2018 Q4	385.34 Million CNY	0.0%
2018 Q1	- CNY	0.0%
2017 FY	162.56 Million CNY	0.0%

Peer Long Term Debt Comparison of Shanghai Henlius Biotech, Inc.

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-4122.769%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	69.747%